Syncona completes sale of Blue Earth Diagnostics for $476.3m

09:38 01/08/2019
StockMarketWire.com - Life science investment trust Syncona said it had completed the sale of its portfolio company Blue Earth Diagnostics to Bracco Imaging for $476.3m (£390.2m).

The sale of Blue Earth would generate £336.9m of net proceeds for Syncona for its 89% stake in the business.

This would further strengthen its strategic capital pool which underpinned the execution of its strategy of founding, building and funding global leaders in life science, the company said.

At 9:38am: (LON:SYNC) Syncona Ltd share price was +3p at 257p


Story provided by StockMarketWire.com

Forex

Commodities

What the Papers Say

telegraph financial times daily mail daily express independent times
21:39 FirstFT: Today’s top stories 
source: FT.com
21:33 PG&E sinks to 7-month low on new wildfire...
source: FT.com
21:30 Wall Street rises for third day while...
source: FT.com
20:09 China social media accounts suspended over...
source: FT.com
19:48 Banking bodies look at shorter trading day...
source: FT.com
19:47 Hong Kong billionaire to buy pub group...
source: FT.com
19:46 Royal Mail accord with workers is...
source: FT.com
19:45 Markets rally despite new Germany...
source: The Guardian
19:20 Saxo chief predicts more fintech takeovers
source: FT.com
19:16 Auction blunder sees sale of oldest...
source: The Daily Mail
[more ...]